Remember, it was only a few years ago that this stock hit .20 a share on A LOT LESS going on. Truly a mystery as to why this stock isn't now averaging that number....AND THEN SOME... And I agree with Nupapa. This company does NOT have adequate PR exposure as other infamous (or in some cases "notorious") med/pharma have with considerably less going on. It's a secret that's growing tired and pointless, if the intent was to keep this company under the radar. Some good ol' bluster and fanfare is not only deserved, it is now essential. I hope this isn't destined to become the Tucker car of medicine.